genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Eye Disorders

      Prime Editing Reverses Vision Loss in Mice

      3D illustration Rendering of binary code pattern.Futuristic Particles digital Landscape wave Abstract background for business,Science and technology
      Artificial Intelligence

      AI-Proofing Workflows in Drug Development

      Lung Cancer
      Cancer

      New Drug Combo Reduces Lung Tumors in Mice

      Corn crop
      AgBio

      Gene Discovery May Help Effort to Breed Climate Resilient Crops

      RNA strands consisting of nucleotides important for protein bio-synthesis
      Cancer

      Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Abstract Colorful Blue Radial Glitch Chromatic Holographic Background
      Cancer

      Lightspeed’s Jonathan MacQuitty and the Laws of Biotech Relativity

      scientists workin
      Biologics

      Biologics Manufacturing without the Cells

      Bioprocessing

      Bio-Inspired Coatings Could Make Cell Activation More Efficient in Therapy Production

      Bioprocessing

      Vortex-Focusing Microfluidics Yields Precisely Sized Liposomes at Scale

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • GEN Edge
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
    • Videos
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home Cancer Sarcoma

Sarcoma

  • Anal Cancer
  • Bladder Cancer
  • Bone Marrow Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer Associated Pain
  • Cervical Cancer
  • Colorectal Cancer
  • Endometrial Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • Head and Neck Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Mesothelioma
  • Multiple Myeloma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Sarcoma
  • Skin Cancer
  • Stomach Cancer
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Eye Disorders

    StockWatch: Failed Trial Sinks NGM Bio; Will Merck Opt Into Eye Disorder Drug?

    Sarcoma

    Epizyme Charts Five-Year Clinical Vision, Seeing Silver Linings Amid Tazverik Clouds

    lungs of a mouse with Ewing sarcoma
    Sarcoma

    Keeping Child Bone Cancer in Check through Signaling Hormone

    Kaposi sarcoma. Source: Wikimedia Commons
    Sarcoma

    3D Structure of Virus Linked to Kaposi’s Sarcoma May Open Door to New Antiviral Therapies

    Sarcoma

    Lion Biotechnologies, MD Anderson Plan Clinical Trials of TIL Cancer Therapy

    Sarcoma

    CytRx’s Aldoxorubicin Disappoints in Phase III Trial

    Sarcoma

    Novel Protein May Open Door to New Therapies for Infection and...

    Sarcoma

    3D Scaffold System May Lead to Novel Anticancer Therapies

    Sarcoma

    Ziopharm Restructuring After Phase III Failure

    Sarcoma

    PharmaEngine Nabs Rights to Nanoparticle Radiotherapy Booster

    Sarcoma

    GSK’s Votrient Approved in U.S. for Treating Soft Tissue Sarcoma

    Small molecule inhibitor acted on mutated ETS transcription factors to reduce cell invasiveness and motility. [© Orlando Florin Rosu - Fotolia.com]
    Sarcoma

    Researchers Find Ewing’s Sarcoma Candidate Blocks Oncogenic Gene in Prostate Cancer

    Sarcoma

    MabVax Wins $1.8M SBIR Grant to Support Phase II Sarcoma Vaccine...

    Sarcoma

    Ariad Reports Phase III Success with Drug for Metastatic Soft-Tissue or...

    For $50 million up front and the potential for up to $514 million in milestones
    Sarcoma

    Merck Gains Control of Ariad’s Ridaforolimus Program

    Recently Featured

    Prime Editing Reverses Vision Loss in Mice

    Prime Editing Reverses Vision Loss in Mice

    AI-Proofing Workflows in Drug Development

    AI-Proofing Workflows in Drug Development

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Gene Discovery May Help Effort to Breed Climate Resilient Crops

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Novel Approach Delivers Therapeutic RNA Molecules to Selectively Target Cells

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up